Shaping the Future World of Health

6/13/2018, 6:30 PM to 8:00 PM | German House New York

Medicine and Life Sciences are two vast areas of scientific inquiry and research. A constant flow of discoveries, theories and therapeutic approaches produces immense amounts of data and information. How can researchers and health care providers keep up? How can they know which approach is the right one for the individual patient? In comes Precision Medicine (PM), which utilizes modern technological approaches such as big data analysis, artificial intelligence and additive manufacturing, to name just a few. As a contemporary answer to an age-old problem, PM holds the promise of tailoring therapeutic approaches to specific patients, their unique biography and even their DNA. The question is, can it live up to the hype?

   

In its brand-new series on “Precision Medicine” (June 2018 to December 2019) the German Center for Research and Innovation examines the four core areas: (1) diagnostics, (2) data mapping of diseases, (3) targeted therapies and, finally, (4) individualized drugs. This exchange of new knowledge, ideas and solutions among all stakeholders will contribute to a transatlantic dialogue between the US and Germany on science, teaching, corporate work, policy support and patient´s expectations.

 

The inaugural event, June 13, will set the stage by looking at the big picture: What can we expect from precision medicine? Where are we headed in the future world of health? Join the discussion with experts from the universities of Freiburg and Rochester, the Dana-Farber Cancer Institute and the two global pharma companies Pfizer, USA, and Bayer, Germany!

 

The panel is followed by a networking reception. Registration is required.

To RSVP by June 11, please click here.